| Synthesis, pharmacological and toxicological evaluation of amide derivatives of ibuprofen N Mehta, S Aggarwal, S Thareja, P Malla, M Misra, TR Bhardwaj, ... International Journal of Chem Tech Research 2 (1), 233-238, 2010 | 35 | 2010 |
| Advances in the design and discovery of drugs for the treatment of prostatic hyperplasia R Kumar, P Malla, M Kumar Expert opinion on drug discovery 8 (8), 1013-1027, 2013 | 19 | 2013 |
| Saxagliptin: a new drug for the treatment of type 2 diabetes S Thareja, S Aggarwal, P Malla, D Haksar, T Raj Bhardwaj, M Kumar Mini Reviews in Medicinal Chemistry 10 (8), 759-765, 2010 | 18 | 2010 |
| Ramping glucosuria for management of type 2 diabetes mellitus: An emerging cynosure P Malla, R Kumar, MK Mahapatra, M Kumar Medicinal Research Reviews 34 (6), 1146-1167, 2014 | 13 | 2014 |
| Design of potent human steroid 5α-reductase inhibitors: 3D-QSAR CoMFA, CoMSIA and docking studies R Kumar, P Malla, A Verma, M Kumar Medicinal Chemistry Research 22, 4568-4580, 2013 | 13 | 2013 |
| Validation of Formylchromane Derivatives as Protein Tyrosine Phosphatase 1 B Inhibitors by Pharmacophore Modeling, Atom‐Based 3 D‐QSAR and Docking Studies P Malla, R Kumar, M Kumar Chemical biology & drug design 82 (1), 71-80, 2013 | 11 | 2013 |
| In silico accounting of novel pyridazine analogues as h-PTP 1B inhibitors: pharmacophore modelling, atom-based 3D QSAR and docking studies MK Mahapatra, R Kumar, P Malla, M Kumar Medicinal Chemistry Research 23, 2701-2711, 2014 | 8 | 2014 |
| A paradigm for development of novel PTP 1B inhibitors: Pharmacophore modelling, atom-based 3D-QSAR and docking studies P Malla, R Kumar, SK Mattewal, MK Mahapatra, M Kumar Medicinal Chemistry Research 23, 927-938, 2014 | 7 | 2014 |
| Pharmacophore modeling, atom based 3D-QSAR and docking studies of protein tyrosine phosphatase 1B inhibitors P Malla, R Kumar, M Kumar Letters in Drug Design & Discovery 10 (4), 303-319, 2013 | 3 | 2013 |
| Synthesis of novel 17-Oxo-17a-Aza-D-Homo-3, 5-seco-steroids as potential 5α-reductase inhibitors M Kumar, S Aggarwal, S Thareja, P Arora, P Malla, TR Bhardwaj Journal of the Iranian Chemical Research 4 (3), 211, 2009 | 3* | 2009 |
| 3D-QSAR studies on a series of 2, 4-thiazolidinedione derivatives: a self-organizing molecular field analysis approach to design novel PTP 1B inhibitors P Malla, M Kumar Medicinal Chemistry 9 (6), 828-845, 2013 | 2 | 2013 |
| Accounting of ligand–receptor interactions to explore and design novel architecture for PTP 1B inhibition: a legitimate approach P Malla, R Kumar, M Kumar Journal of Chemometrics 26 (11-12), 576-584, 2012 | 2 | 2012 |
| Quantitative Structural Activity Relationship Studies for In Silico Prediction of In Vitro Cytotoxicity of NSAIDs in Colon Cancer Cell Lines H Goel, S Thareja, P Malla, M Kumar, V R Sinha Letters in Drug Design & Discovery 9 (8), 755-763, 2012 | 1 | 2012 |
| In silico predicative studies for cytotoxic potential of NSAIDs using self-organizing molecular field analysis H Goel, S Thareja, P Malla, M Kumar, VR Sinha International Journal of Toxicology 31 (4), 390-396, 2012 | 1 | 2012 |
| Synthesis, Biological Evaluation and in silico Studies of Novel 5α-aza-Bhomo-3, 5-secosteroids as Potential 5-reductase Inhibitors R Kumar, P Chauhan, P Malla, M K Mahapatra, R W Hartmann, ... Letters in Drug Design & Discovery 13 (9), 869-878, 2016 | | 2016 |
| Synthesis and study of novel protein tyrosine phosphatase 1B inhibitors for the management of type 2 diabetes mellitus P Malla Chandigarh, 0 | | |
